Summary
The findings presented in this study are based on 29.226 autopsies performed (between 1953 and 1977) at Basel University on adult inhabitants of Basel, from which 409 urinary tract tumors (UTT) and 513 phenacetin abusers (PA) were discovered. There were 44 (8.6%) PA with UTT which, when compared with the control group (1.27%), represents a statistically significant increased incidence. Of the 50 UTT in PA, 52% occurred in the bladder, 6% in the ureter, and 42% in the renal pelvis. The induction time for tumors of the urinary bladder was about 27 years, and for tumors of the renal pelvis about 20 years. The commonest tumors arising in PA were invasive solid and non-invasive papillary urothelial carcinomas. PA with UTT died earlier than nonabusers but had metastases as frequently as nonabusers. Analgesic nephropathy was not always an accompanying disease. The daily dose of g/phenacetin in tumor patients in general, and in patients with tumors of the urinary bladder in particular, was about 1 g lower than in patients with analgesic nephropathy (without tumors) and in those with tumors of the renal pelvis. Thus, for the localization of the tumors, the daily dose seems to be more important than the total dose. Our investigation proved that not only tumors of the renal pelvis, but also of the ureter and the urinary bladder, are significantly more frequent in PA than in nonabusers. It is suspected that despite restriction of the over-the-counter sale of phenacetin-containing analgesics and even after stopping any analgesic abuse, UTT will further increase due to the longer induction time. Routine cytological screening tests of the urine are recommended for all known PA. A prescription for all phenacetin- and paracetamol-containing analgesics is necessary.
Similar content being viewed by others
References
Bengtsson U (1974) Phenacetin and renal pelvic carcinoma. Clin Nephrol 2:123–126
Bengtsson U, Angervall L (1970) Analgesic abuse and tumors of renal pelvis. Lancet I:305
Bengtsson U, Angervall L, Ekman H, Lehmann L (1968) Transitional-cell tumours of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 2:145–150
Bengtsson U, Johansson S, Angervall L (1978) Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int 13:107–113
Bennington JL, Beckwith JB (1975) Tumors of the kidney, renal pelvis and ureter. Atlas of tumor pathology AFJP, 2nd series, vol 12, pp 243
Blohme J, Johannson S (1981) Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. Kidney Int 20:671–675
Bock KD (1973) Analgetika-Abusus und maligne Nierenbeckentumoren. In: E. Haschek (Hrsg): Probleme des Phenacetin-Abusus. Egermann, Wien, pp 227–233
Brunner FP, Richtmann L, Thiel G, Dubach UC (1978) Tumoren der ableitenden Harnwege und Analgetikaabusus. Schweiz Med Wochenschr 108:1013–1019
Dalquen P, Fasel J, Mihatsch MJ, Rist M, Rutishauser G (1980) Phenacetinabusus IV. Sind zytologische Harnuntersuchungen in der Tumorvorsorge bei Phenaceinabusern erfolgversprechend und anwendbar. Schweiz Med Wochenschr 110:302–306
Druckrey H, Preussmann R, Ivanovic S, Schmähl D (1967) Organotrope karzinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69:103–201
Farber E, Cameron HM, Linsell DA, Warwick GP (1976) The pathology of experimental liver cell cancer. In: Liver cell cancer. Elsevier Scientific Publishing Company, Amstertam, New York, Oxford
Grob HU (1971) Phenacetinabusus und Nierenbeckenkarzinom. Helv Chir Acta 38:537–539
Gsell O (1974) Nephropathie durch Analgetika. Ergeb Inn Med Kinderheilk (Neue Folge) 35:68–175
Hultengren N, Lagergren C, Ljungqvist A (1965) Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand 130:314–320
Johansson S, Angervall L, Bentsson U, Wahlqvist L (1974) Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics. Cancer 33:743–753
Johannson S, Wahlqvist L (1977) Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathol Microbiol Scand [A] 83:768–774
Küng LG (1976) Hypernephroides Karzinom und Karzinome der ableitenden Harnwege nach Phenacetinabusus. Schweiz Med Wochenschr 106:47–51
Leistenschneider W, Ehmann R (1973) Nierenbeckenkarzinom nach Phenacetinabusus. Schweiz Med Wochenschr 103:433–439
Leistenschneider W, Nagel R (1977) Urotheltumoren und Phenacetinabusus. Therapiewoche 27:4221–4230
Macklin AW, Welch RM, Cuatrecasas P (1979) Drug safety: Phenacetin. Science 205:144–147
Mihatsch MJ (1982) Unpublished data
Mihatsch MH, Bleischer A, Six P, Heitz PhU (1972) Primary choriocarcinoma of the kidney in a 49 year old woman. J Urol 108:537–539
Mihatsch MJ, Torhorst J, Steinmann E, Hofer M, Stickelberger M, Bianchi L, Berneis K, Zollinger HU (1979) The morphologic diagnosis of analgesic (phenacetin) abuse. Pathol Res Pract 164:68–79
Mihatsch MJ, Manz T, Knüsli C, Hofer HO, Rist M, Guetg R, Rutishauser G, Zollinger HU (1980) Phenacetinabusus III. Maligne Harnwegstumoren bei Phenacetinabusus, Basel 1963–1977. Schweiz Med Wochenschr 110:255–264
Miller JA (1979) Carcinogenesis by chemicals. G.H.A. Clowes memorial lecture. Cancer Res 30:559–576
Raaflaub J, Dubach UC (1969) Dose dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy. Klin Wochenschr 47:1286–1287
Sachs L (1974) Angewandte Statistik 4. Aufl. Springer, Berlin Heidelberg New York
Skarbanek P (1981) In: Walsh A (ed) Bladder cancer. UJCC Report No 13, Geneva, pp 131
Zetterlund CG (1973) Phenacetin takers with urinary tract tumours — “Hjorton's syndrome“. In: E. Haschek (Hrsg) Probleme des Phenacetin-abusus. Egermann, Wien, pp 247–252
Zollinger HU (1966) Niere und ableitende Harnwege. In: Doerr W, Uehlinger E (Hrsg) Handbuch der speziellen pathologischen Anatomie, Bd 3. Springer, Berlin Heidelberg New York, S 390–487
Johansson SL (1981) Carcinogenicity of analgesics: long term treatment of Sprague-Dawley rats with phenacetin, phenazone, coffein and paracetamol (acetaminophen). Int J Cancer 27:521–529
Author information
Authors and Affiliations
Additional information
Dedicated to Herrn Prof. Dr. H.U. Zollinger on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Mihatsch, M.J., Knüsli, C. Phenacetin abuse and malignant tumors. Klin Wochenschr 60, 1339–1349 (1982). https://doi.org/10.1007/BF01716213
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716213